This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
AB InBev: Brewing Up Forecasts during COVID-19
Foley, C. Fritz; Egan, Mark; Cekin, Esel; Billaud, EmilieCase HBS-224020-EFinanceIn July 2021, the CEO of AB InBev's European operations and his team strategized to position the company for success post-pandemic. As the world's largest beer company, boasting over 500 brands, revenue of $46 billion, and a workforce of 160,000 in 2020, AB InBev grappled with the repercussions of the pandemic, particularly the adverse effects on on-trade customers like bars and restaurants. Historically a traditional firm in a conventional indus...Starting at €8.20
-
Transforming Alkermes into a Global Biopharmaceutical Company
Foley, C. Fritz; Haas, NicholasCase HBS-215079-EFinanceIn the summer of 2011, Jim Frates, CFO of Alkermes faced choices about how to finance the acquisition of Dublin, Ireland-based Elan Drug Technologies (EDT) - a deal that was expected to close in the fall. The case describes the history of Alkermes, provides information about the planned merger, and details the funding options. The case gives students the opportunity to analyze the role CFOs play in biopharmaceutical firms, to evaluate the attract...Starting at €8.20
-
Legrand's Acquisition of Milestone
Foley, C. Fritz; Boland, F. KatelynnCase HBS-220028-EFinanceIn June 2017, Legrand, a global specialist in electrical and digital building infrastructure which was a serial acquirer, announced it had signed an agreement to buy Milestone AV Technologies, a leading designer and manufacturer of branded audio-video products. This case describes Legrand's approach to screening, pursuing, and integrating targets as well as the criteria used to evaluate if a deal is successful.Starting at €8.20